Feb. 4 at 2:12 PM
Earnings beat for
$CBT — but what's next for the stock? 🤔
Adjusted EPS hit
$1.53, topping the Zacks Consensus Estimate of
$1.40, despite an 11.1% net sales drop and a 14.9% drop in Reinforcement Materials sales 📉. Performance Chemicals delivered an EBIT boost, thanks to cost management and a favorable product mix, although this was partly offset by lower volumes due to weak demand in Europe.
See the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2828748/cabot-q1-earnings-beat-estimates-sales-down-yy-on-lower-volumes?cid=sm-stocktwits-2-2828748-body-31881&ADID=SYND_STOCKTWITS_TWEET_2_2828748_BODY_31881